Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum TruTrace Technologies Inc. C.TTT

Alternate Symbol(s):  TTTSF

TruTrace Technologies Inc is a full-service software company that operates an integrated blockchain platform which registers and tracks cannabis intellectual property from genome to sale. It also monitors the process of genetic and quality-control testing for legal cannabis.

CSE:TTT - Post Discussion

TruTrace Technologies Inc. > Investor deck released: Annual Market Revenue 151.3M$
View:
Post by ConnectTheDot1 on Jan 18, 2019 4:09pm

Investor deck released: Annual Market Revenue 151.3M$

Finally they released the investor deck! With a Revenue Model of 151.3M$ Total market available for BlockStrain! Enjoy.. https://blockstrain.io/wp-content/uploads/2019/01/20190117-blockstrain-investor-overview-small.pdf
Comment by Mbillrd on Jan 18, 2019 5:23pm
Nice! Finally some potential numbers. Just need the clients now!
Comment by LaserStock29 on Jan 18, 2019 7:58pm
Actually do the numbers. Find out our pps with weedmd alone should be $1+
Comment by Mbillrd on Jan 18, 2019 9:33pm
If there numbers are correct and we get most of the market could be over $10 pps 
Comment by Mbillrd on Jan 18, 2019 9:35pm
their* but as with any stock it could go either way...
Comment by LaserStock29 on Jan 18, 2019 11:32pm
Well it's likely WeedMD has a real nice year based on their expansion and Shoppers license coming online. WMD is 208m into a total market valuation  works out with a 6-8x multiple to be around $1. Q1 2019 would be very nice ride to hit that pps. Hope the investors at Cantech in Toronto 29-30th see the proposition in a similar light.
Comment by Mbillrd on Jan 19, 2019 3:47am
Agreed, some good numbers for Q1 would go a long way. If we get some interest and the big money starts investing this thing could take off going into Q2, we can only hope! GLTA
Comment by fic73 on Jan 19, 2019 4:44am
Finally, good indication of potential numbers. One question though on their "Total available market for Blockstrain: 151.3 M. Are these numbers Blockstrain is expecting as for their potetial revenue or this is the total potential market for all companies in this field of testing, tracking and verification? If Blockstrain could get 50% (75M), with a multiple of 7 the potential market cap would ...more  
Comment by LaserStock29 on Jan 19, 2019 10:01am
Well I just assume the 151.3M is a Total Potenial Revenue for 'ALL' companies  Total cap 3b Weed MD 208m    3b/208 = 15 roughly 151.3/15 = 10m Multiple 6-8x roughly for SaaS technology  into 80m shares  is about .75-$1 Why bother looking beyond the one deal that's done.  Been holding 8 months.. bout time this gets it's due valuation ...more  
Comment by fic73 on Jan 19, 2019 11:46am
Thanks Laser. I am not sure about your mathematical model if that is correct. Also I highly doubt that this contract with weedMD worth 10 millions. If we use your mathematical model then ACB has a MC of around 8.5B. How that would translate to BlockStrain revenue if we get contract with them.
Comment by LaserStock29 on Jan 19, 2019 12:24pm
I'm going strictly by the investors deck as an absolute. So 3b is a total cap. 151m is a total revenue number Weed MD fills 208m of 3b To your question, Aurora has a cap of 8.4b and is disqualified from said assumptions. Why? Unless I am mistaken the blueberry pie is 3b. So to hit 3b cap, find 14 more companies of 200m cap or one worth 2.8b two of 1.4b etc. I'm just calculating the best I ...more  
Comment by LaserStock29 on Jan 19, 2019 12:54pm
Just got to wait for more details of how this works. Honestly I'd rather more LPs get onboard before cantech conference eom Have a good weekend
Comment by ConnectTheDot1 on Jan 19, 2019 2:58pm
They based the market of 6B$ as follows(based on quantity not capitalization of companies) // 10$/gram // 600 000kg // 3.4kg/batch // 176 000batches (600 000/3.4) // Mandatory testing: as 600$/batches MANDATORY TESTING Average Price Microbiological: $200 per test Average Price Chemistry: $1600 per test Average Price Pesticide: $600 per test Total Testing Cost Per Batch: $2400 BLOCKStrain ...more  
Comment by LaserStock29 on Jan 21, 2019 10:23am
Genetics from Jan 2018 Genetics Sept 2018 Plant Breeders Rights Nov 2018 Just reading this stuff... the bureaucracy around this.. having IP Genetic information lab verified on the Blockchain accessible via software to streamline and make transparent all this information is absolutely necessary IMO. Hope those big guys at Cantech see this software as the International solution Kudos to ...more  
Comment by ConnectTheDot1 on Jan 21, 2019 10:35am
DNAX claims in description at Cantech as: "BLOCKStrain is The Big Data Solution to Cannabiss Biggest Problem" Interesting to note that BlockStrain will share the stage on 30th at 11:00 with its rivalDMG Blockchain on "!Cannabis: A Real Use Case for Blockchain" With the 2 CEOs Dan Reitzik, Robert Galarza!" DNAX has its sole presentation later at 2:50 https://cambridgehouse ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities